道琼斯指数
52,342.56
涨跌
-132.54-0.25%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场走势分化,道琼斯指数涨跌幅为 -0.25%,标普 500 指数为 -0.30%,纳斯达克综合指数为 -1.38%。个股方面,2,646 只上涨、2,470 只下跌,市场整体呈现分化格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 51 | 4D Molecular Therapeutics, Inc.FDMT | $12.77 | -1.24% | 552.41K | $705.63M | $6.96 - $16.93 | 0.00% |
| 52 | Ginkgo Bioworks Holdings, Inc.DNA | $12.73 | -8.68% | 2.66M | $705.04M | $5.37 - $18.22 | 0.00% |
| 53 | Solid Biosciences Inc.SLDB | $6.39 | -1.23% | 813.98K | $685.38M | $3.79 - $11.45 | 0.00% |
| 54 | Candel Therapeutics, Inc.CADL | $8.64 | -0.35% | 612.39K | $660.81M | $4.35 - $14.00 | 0.00% |
| 55 | Aura Biosciences, Inc.AURA | $6.30 | -1.56% | 680.89K | $653.24M | $4.73 - $9.54 | 0.00% |
| 56 | DBV Technologies S.A.DBVT | $10.31 | -3.38% | 1.01M | $648.02M | $8.63 - $26.18 | 0.00% |
| 57 | Attovia Therapeutics, Inc.ATTO | $15.30 | -3.42% | 394.69K | $633.64M | $12.94 - $28.00 | 0.00% |
| 58 | Entera Bio Ltd.ENTX | $3.12 | +0.65% | 136.76K | $543.33M | $0.91 - $4.20 | 0.00% |
| 59 | NRC HealthNRC | $23.43 | +0.21% | 101.58K | $527.94M | $11.73 - $24.36 | 0.02% |
| 60 | aTyr Pharma, Inc.ATYR | $5.34 | +3.97% | 225.54K | $523.69M | $0.99 - $44.40 | 0.00% |
| 61 | REGENXBIO Inc.RGNX | $7.42 | +2.62% | 729.30K | $490.08M | $5.46 - $16.19 | 0.00% |
| 62 | Editas Medicine, Inc.EDIT | $2.92 | -0.68% | 2.93M | $449.22M | $1.66 - $3.94 | 0.00% |
| 63 | Allogene Therapeutics, Inc.ALLO | $1.25 | -3.46% | 6.95M | $433.59M | $1.04 - $4.46 | 0.00% |
| 64 | C4 Therapeutics, Inc.CCCC | $3.31 | -2.50% | 2.37M | $406.60M | $1.69 - $5.17 | 0.00% |
| 65 | Tectonic Therapeutic, Inc.TECX | $20.49 | -0.27% | 109.80K | $400.59M | $15.52 - $39.53 | 0.00% |
| 66 | Fennec Pharmaceuticals Inc.FENC | $10.94 | +0.46% | 156.26K | $384.42M | $5.65 - $13.25 | 0.00% |
| 67 | Zura Bio LimitedZURA | $3.84 | -11.61% | 3.18M | $367.79M | $3.25 - $7.44 | 0.00% |
| 68 | Kyverna Therapeutics, Inc.KYTX | $5.84 | -0.85% | 740.97K | $361.29M | $5.16 - $13.67 | 0.00% |
| 69 | Surrozen, Inc.SRZN | $29.45 | -3.03% | 233.32K | $341.98M | $11.39 - $37.83 | 0.00% |
| 70 | IRulya Therapeutics Inc.IRLA | $31.28 | -5.56% | 63.33K | $339.14M | $25.13 - $41.00 | 0.00% |
| 71 | X4 Pharmaceuticals, Inc.XFOR | $3.35 | -1.33% | 819.55K | $331.65M | $2.43 - $4.83 | 0.00% |
| 72 | Agenus Inc.AGEN | $7.09 | -0.63% | 523.22K | $320.24M | $2.71 - $10.31 | 0.00% |
| 73 | ProKidney Corp.PROK | $1.47 | -3.95% | 707.95K | $306.08M | $1.30 - $3.27 | 0.00% |
| 74 | Eikon Therapeutics, Inc.EIKN | $5.34 | -3.61% | 511.41K | $300.07M | $5.29 - $17.40 | 0.00% |
| 75 | Scribe Therapeutics Inc.SCTX | $17.43 | -0.91% | 228.38K | $295.33M | $13.50 - $39.60 | 0.00% |
| 76 | SAB Biotherapeutics, Inc.SABS | $3.24 | +0.94% | 414.27K | $294.70M | $2.44 - $5.15 | 0.00% |
| 77 | Cabaletta Bio, Inc.CABA | $1.58 | +3.95% | 4.91M | $268.73M | $1.32 - $4.23 | 0.00% |
| 78 | Century Therapeutics, Inc.IPSC | $1.46 | -2.67% | 1.38M | $263.46M | $0.43 - $3.04 | 0.00% |
| 79 | Fate Therapeutics, Inc.FATE | $2.17 | +0.46% | 757.54K | $260.61M | $0.95 - $3.23 | 0.00% |
| 80 | Ocugen, Inc.OCGN | $0.75 | -3.09% | 5.14M | $253.99M | $0.70 - $2.73 | 0.00% |
| 81 | Lexeo Therapeutics, Inc.LXEO | $3.06 | -2.24% | 901.83K | $251.47M | $2.55 - $10.99 | 0.00% |
| 82 | Alector, Inc.ALEC | $2.25 | -0.44% | 1.26M | $250.67M | $1.09 - $2.76 | 0.00% |
| 83 | Inhibikase Therapeutics, Inc.IKT | $1.67 | +3.09% | 761.27K | $233.58M | $1.33 - $2.61 | 0.00% |
| 84 | Artiva Biotherapeutics, Inc.ARTV | $4.23 | -1.17% | 1.75M | $206.61M | $2.96 - $14.53 | 0.00% |
| 85 | Palisade Bio, Inc.PALI | $1.19 | -0.42% | 3.37M | $206.51M | $1.10 - $2.85 | 0.00% |
| 86 | Precision BioSciences, Inc.DTIL | $7.43 | -0.67% | 142.00K | $205.16M | $3.53 - $9.62 | 0.00% |
| 87 | Alpha Cognition Inc.ACOG | $9.21 | +0.98% | 60.85K | $200.57M | $4.50 - $10.14 | 0.00% |
| 88 | MaxCyte, Inc.MXCT | $1.73 | -0.29% | 1.08M | $178.03M | $0.64 - $1.80 | 0.00% |
| 89 | Invivyd, Inc.IVVD | $0.60 | -3.08% | 2.85M | $176.86M | $0.53 - $3.07 | 0.00% |
| 90 | Acumen Pharmaceuticals, Inc.ABOS | $2.29 | -3.57% | 739.88K | $165.97M | $1.50 - $3.60 | 0.00% |
| 91 | Sutro Biopharma, Inc.STRO | $9.19 | -1.02% | 206.10K | $152.36M | $7.15 - $43.85 | 0.00% |
| 92 | Protara Therapeutics, Inc.TARA | $2.52 | +1.00% | 477.77K | $148.63M | $2.28 - $7.82 | 0.00% |
| 93 | Coherus Oncology, Inc.CHRS | $0.90 | -22.56% | 6.06M | $138.90M | $0.81 - $2.62 | 0.00% |
| 94 | Compass Therapeutics, Inc.CMPX | $0.76 | -0.38% | 1.70M | $136.51M | $0.73 - $6.88 | 0.00% |
| 95 | Humacyte, Inc.HUMA | $0.47 | -0.64% | 3.63M | $130.01M | $0.34 - $1.78 | 0.00% |
| 96 | Anavex Life SciencesAVXL | $1.30 | -0.38% | 794.13K | $120.97M | $1.14 - $8.35 | 0.00% |
| 97 | Outlook Therapeutics, Inc.OTLK | $0.49 | -9.71% | 6.97M | $119.29M | $0.16 - $2.54 | 0.00% |
| 98 | LENZ Therapeutics, Inc.LENZ | $3.49 | +8.41% | 5.85M | $109.56M | $2.79 - $32.13 | 0.00% |
| 99 | Voyager Therapeutics, Inc.VYGR | $1.75 | -4.35% | 543.42K | $108.14M | $1.70 - $5.48 | 0.00% |
| 100 | Black Diamond Therapeutics, Inc.BDTX | $1.85 | +1.37% | 487.87K | $106.58M | $1.60 - $4.94 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。